Calcium Acetate NDC 60687-589

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-589Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0589Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-589-65	60687058965	50 BLISTER PACK in 1 CARTON (60687-589-65) / 1 CAPSULE in 1 BLISTER PACK (60687-589-11)Marketed from Jul 5, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcium Acetate
Generic name (nonproprietary): calcium acetate
Active ingredients: Calcium acetate — 667 mg/1
Dosage form: Capsule
Route: Oral
Labeler: American Health Packaging
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203135
Marketing start: Jul 5, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 60687-589_5aaba361-3fc5-712f-e063-6294a90a39f0SPL ID 5aaba361-3fc5-712f-e063-6294a90a39f0SPL set ID 2072d9f4-abb1-4699-bde5-6041dd79cad5RxCUI 359296UNII Y882YXF34X
Pharmacologic class: Blood Coagulation Factor; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687058965 followed by a unit qualifier and the quantity

Package 60687-0589-65. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 4, 2026.

Indications (excerpt from the label)

Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203135

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203135
Product	Strength	Form · route	Labeler	Product NDC
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	EXELAN PHARMACEUTICALS, INC.	76282-377
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	Cipla USA Inc.,	69097-862